What Vitamins Are Good for Macular Degeneration? The AREDS2 Formula Explained
Medical disclaimer: This article is for informational purposes only and is not medical advice and is not a substitute for diagnosis or treatment from an ophthalmologist. Macular degeneration is a diagnosed eye disease that requires professional monitoring and care. Statements have not been evaluated by the FDA. This content does not diagnose, treat, cure, or prevent any disease.
This article does not recommend or endorse any specific commercial supplement for macular degeneration, and no product reviewed on this site is a substitute for the clinically studied AREDS2 formula or for professional eye care. If you have been diagnosed with macular degeneration, or are concerned you may have it, see an ophthalmologist.
This article exists purely to explain, accurately and carefully, what the actual clinical research says about vitamins and age-related macular degeneration (AMD). It is written for education, not as a supplement recommendation of any kind, and it does not suggest that any commercially sold product replicates or replaces the clinical formula described below.
Quick Answer
The only vitamin and mineral combination with strong clinical trial evidence for macular degeneration is the specific AREDS2 formula, studied by the National Eye Institute in people who already had intermediate AMD or advanced AMD in one eye. It is not a cure and it does not apply to everyone. This is a decision for you and your ophthalmologist, not a supplement to choose on your own.
What Age-Related Macular Degeneration Is
Age-related macular degeneration is a diagnosed eye disease affecting the macula, the part of the retina responsible for sharp, central vision, and it is a leading cause of vision loss in older adults. It comes in early, intermediate, and advanced stages, and only an eye doctor, using a dilated eye exam and imaging, can diagnose it and determine its stage. Nothing in this article is a substitute for that diagnosis.
What AREDS2 Actually Found
The Age-Related Eye Disease Study 2 (AREDS2), funded by the National Eye Institute, part of the NIH, tested a specific daily vitamin and mineral formula in people who already had intermediate AMD or advanced AMD in one eye. The AREDS2 formula consists of vitamin C (500 mg), vitamin E (400 IU), lutein (10 mg), zeaxanthin (2 mg), zinc (80 mg, or 25 mg in a lower-zinc version tested), and copper (2 mg, added specifically to offset high-dose zinc). In the specific population studied, this formula was associated with a reduced risk of progression to advanced AMD over the study period. Beta-carotene, used in the original AREDS1 formula, was replaced with lutein and zeaxanthin in AREDS2 after research linked beta-carotene to increased lung cancer risk in smokers.
Who This Research Applies To, and Who It Doesn’t
The AREDS2 findings apply specifically to people who already have intermediate AMD, or advanced AMD in one eye, the exact population studied. There is no equivalent large-scale clinical evidence that this formula, or any of its individual nutrients, prevents AMD from ever developing in someone with early or no signs of the disease. Taking these vitamins as a healthy person with no diagnosed AMD is not the same claim as what the research actually supports, and no commercial product should be assumed to prevent AMD on that basis.
Why This Isn’t a “Best Supplement” Question
Because AREDS2 is a specific, tested clinical formula at specific doses, the relevant question for someone with diagnosed AMD isn’t “which commercial eye vitamin is best,” it’s “does this specific product match the AREDS2 formula and dosing, and has my ophthalmologist recommended it for my specific stage of disease.” A product can legally include lutein and zeaxanthin without being equivalent to, or tested as, the AREDS2 formula. This article deliberately does not rank or recommend any commercial product for this reason.
Bottom Line
The AREDS2 formula is the one vitamin and mineral combination with real clinical trial evidence specific to macular degeneration, and it applies to a specific diagnosed population under an ophthalmologist’s care. If you have been diagnosed with AMD, or are worried you might have it, the right first step is an eye doctor, not a supplement aisle. Ask your ophthalmologist directly whether the AREDS2 formula, or a specific product matching it, is appropriate for your stage of disease.
Frequently Asked Questions
Q: Can I take the AREDS2 vitamins to prevent macular degeneration?
A: The AREDS2 trial studied people who already had intermediate or one-eye advanced AMD, not healthy people trying to prevent the disease from ever starting. There isn’t the same level of evidence for prevention in someone with no diagnosed AMD. Ask an ophthalmologist about your personal risk factors.
Q: Does every eye vitamin supplement contain the AREDS2 formula?
A: No. Many eye-health supplements include some of the same ingredients (lutein, zeaxanthin, vitamin C, zinc) but at different doses, or without the copper included specifically to offset high-dose zinc. Check the label against the actual AREDS2 doses, or ask your ophthalmologist to confirm, rather than assuming.
Q: Should I ask my eye doctor before taking any eye vitamin?
A: Yes, especially if you have been diagnosed with AMD or any other eye condition, and especially regarding zinc, since the AREDS2 zinc dose (80 mg) is well above typical multivitamin levels and can interact with copper absorption and certain medications.
Q: Are lutein and zeaxanthin available separately from the full AREDS2 formula?
A: Yes, many products sell lutein and zeaxanthin alone or in different combinations. These are not the same as the tested AREDS2 formula, which included specific additional ingredients and doses tested together as a unit.
Related Reading
- Are AREDS2-Style Eye Vitamins Safe With Blood Thinners? Zinc, Copper & Interaction FAQ
- Lutein vs Bilberry Extract for Eye Health: Which Has Stronger Evidence?
- Vitamin A: Benefits, Dosage, Best Forms & Safety
- Vision Supplements: The Complete Guide
Sources
- National Eye Institute (NIH): Age-Related Macular Degeneration and the AREDS2 Study
- National Eye Institute (NIH): AREDS/AREDS2 Clinical Trial Details and Formula
These statements have not been evaluated by the Food and Drug Administration. This content is not intended to diagnose, treat, cure, or prevent any disease and is not a substitute for advice from your doctor, ophthalmologist, or pharmacist.